Clinical trial
A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With…
NCT00448591 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00448591 |
|---|---|
| Title | A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer. |
| Official title | An Open-label Study to Evaluate the Safety and Effect on Disease Progression and Overall Survival of Avastin Plus Taxane-based Chemotherapy in Patients With Locally Recurrent or Metastatic Breast Cancer |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | bevacizumab [Avastin], Taxane-based chemotherapy |
| Enrollment | 2,296 |
| Start date | Sep 1, 2006 |
| Primary completion | Feb 1, 2013 |
| Completion | Feb 1, 2013 |
| First posted | Mar 19, 2007 |
| Last update posted | May 25, 2015 |
| Countries | Argentina, Australia, Austria, Brazil, Bulgaria, Canada, China, Colombia, Czechia, Ecuador, Egypt, Estonia and 24 more |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: